APP and Alzheimer disease: As part of its first pathological description, we consistently observed reduced miR‐32533 expression across various AD models, including APP/PS1 mice, 5×FAD mice, and copper‐triggered APPswe cells, consistent with the RNA‐sequencing outcome.